ArticleFrontiers in pharmacology2026

Berberine and celecoxib synergistically suppress non-small cell lung cancer with EGFR/AKT/COX-2-related signaling: network pharmacology, molecular docking and experimental validation.

Qiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.